Seth Harrison MD

Seth Harrison MD General Information

Biography

Dr. Seth Harrison serves as Board Member at Akero Therapeutics. He is the Founder and serves as Managing Partner at Apple Tree Partners (ATP). He serves as Board Member at Ascidian. He serves as a Chairman of the Board at Adendra Therapeutics, Aethon Therapeutics & Initial Therapeutics. He serves as Board Member at Akero Therapeutics & Aulos Bioscience and Ascidian Therapeutics. He also served as Chairman at Intergalactic Therapeutics. He serves as Chairman at Nereid Therapeutics. He served as Chairman at Gala Therapeutics. He serves as Board Member at Evercrisp. He has been investing in life sciences since 1991. He serves as Chairman at Marengo Therapeutics. Prior to starting ATP in 1999, He was a general partner at Oak Investment Partners, and before that a venture partner at Sevin Rosen Funds. He serves as Chairman at Apertor. Some of his earlier investments include Aileron Therapeutics, ArQule, Coelacanth, Cyrano Sciences, Gloucester Pharmaceuticals, HeartWare International, Informed Access, SGX Pharmaceuticals, Syntimmune, Tendyne, Ultracision, and ViroPharma. From 2002 to 2010, he also served on the board of the International Partnership for Microbicides. He received an AB from Princeton University, an MD and MBA both from Columbia University, and completed a surgery internship at the Presbyterian Hospital in the City of New York. He serves as Board Member at Akero Therapeutics, Braeburn, Galaxy Medical, Galvanize Therapeutics, Intergalactic Therapeutics, Marengo Therapeutics, Nereid Therapeutics, Nine Square Therapeutics and Stoke Therapeutics.